Icecure Net Debt from 2010 to 2026
| ICCM Stock | USD 0.57 0 0.65% |
Net Debt | First Reported 2012-09-30 | Previous Quarter -3 M | Current Value -4.7 M | Quarterly Volatility 12.6 M |
Check Icecure Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Icecure Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 400.9 K, Interest Expense of 164.3 K or Selling General Administrative of 10.8 M, as well as many indicators such as Price To Sales Ratio of 18.58, Dividend Yield of 0.0 or PTB Ratio of 7.66. Icecure financial statements analysis is a perfect complement when working with Icecure Medical Valuation or Volatility modules.
Icecure | Net Debt | Build AI portfolio with Icecure Stock |
Evaluating Icecure Medical's Net Debt across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Icecure Medical's fundamental strength.
Latest Icecure Medical's Net Debt Growth Pattern
Below is the plot of the Net Debt of Icecure Medical over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Icecure Medical's Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Icecure Medical's overall financial position and show how it may be relating to other accounts over time.
| Net Debt | 10 Years Trend |
|
Net Debt |
| Timeline |
Icecure Net Debt Regression Statistics
| Arithmetic Mean | (6,572,042) | |
| Coefficient Of Variation | (105.17) | |
| Mean Deviation | 4,549,061 | |
| Median | (4,193,351) | |
| Standard Deviation | 6,911,833 | |
| Sample Variance | 47.8T | |
| Range | 24.2M | |
| R-Value | (0.49) | |
| Mean Square Error | 38.9T | |
| R-Squared | 0.24 | |
| Significance | 0.05 | |
| Slope | (664,848) | |
| Total Sum of Squares | 764.4T |
Icecure Net Debt History
Other Fundumenentals of Icecure Medical
Icecure Medical Net Debt component correlations
Click cells to compare fundamentals
About Icecure Medical Financial Statements
Icecure Medical investors utilize fundamental indicators, such as Net Debt, to predict how Icecure Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Debt | -6.4 M | -6.7 M | |
| Net Debt To EBITDA | 0.42 | 0.82 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of Icecure Medical Correlation against competitors. To learn how to invest in Icecure Stock, please use our How to Invest in Icecure Medical guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Will Health Care Equipment & Supplies sector continue expanding? Could Icecure diversify its offerings? Factors like these will boost the valuation of Icecure Medical. Market participants price Icecure higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Icecure Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.25) | Revenue Per Share | Quarterly Revenue Growth 0.284 | Return On Assets | Return On Equity |
Understanding Icecure Medical requires distinguishing between market price and book value, where the latter reflects Icecure's accounting equity. The concept of intrinsic value - what Icecure Medical's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Icecure Medical's price substantially above or below its fundamental value.
Please note, there is a significant difference between Icecure Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Icecure Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Icecure Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.